Castle Biosciences, Inc. (CSTL) short interest & options flow
NASDAQCSTL heads into the week after its most recent earnings print with an unusual split: sell-side conviction has just strengthened sharply, yet options traders have flipped to their most defensive posture in months. The clearest bullish signal is the analyst tape. Three firms raised price targets in the two days after the November 5 earnings release. Baird lifted its target to $41…
CSTL cost to borrow surges 173% over one week to 0.93%, though remains at low absolute levels; short interest holds at 5.79% of float with high availability.
- Market cap
- $1.05B
- Next earnings
- 26 Feb 2027
Key data as of 12 Nov 2026
CSTL news and analysis
RSSNo long-form analysis yet for CSTL. Pulse alerts and the live data picture are available on ORTEX.
Open CSTL on ORTEX →Want the live picture for CSTL?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CSTL — free to start on ORTEX.
Sign up for free →Open CSTL on ORTEX